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Abstract 
Thymosin beta 4 (Tʲ4) is a member of the
beta-thymosins  family,  a  family  of  peptides
playing essential roles in many cellular func-
tions. Our recent studies suggested Tʲ4 plays a
key role  in the development of human salivary
glands and the gastrointestinal tract. The aim
of this study was to analyse the presence of Tʲ4
in the human adult and foetal genitourinary
tract. Immunolocalization of Tʲ4 was studied
in autoptic samples of kidney, bladder, uterus,
ovary, testicle and prostate obtained from four
human foetuses and four adults. Presence of
the peptide was observed in cells of different
origin: in surface epithelium, in gland epithe-
lial cells and in the interstitial cells. Tʲ4 was
mainly found in adult and foetal bladder in the
transitional  epithelial  cells;  in  the  adult
endometrium, glands and stromal cells were
immunoreactive for the peptide; Tʲ4was main-
ly  localized  in  the  glands  of  foetal  prostate
while, in the adults a weak Tʲ4 reactivity was
restricted to the stroma. In adult and foetal kid-
ney, Tʲ4 reactivity was restricted to ducts and
tubules  with  completely  spared  glomeruli;  a
weak  positivity  was  observed  in  adult  and
foetal  oocytes;  immunoreactivity  was  mainly
localized in the interstitial cells of foetal and
adult testis. In this study, we confirm that Tʲ4
could play a relevant role during human devel-
opment, even in the genitourinary tract, and
reveal that immunoreactivity for this peptide
may change during postnatal and adult life. 
Introduction
Beta-thymosins are N-terminally acetylated
peptides of 5 kDa molecular mass, which are
composed  of  40-44  amino  acid  residues.
1
Thymosyn ʲ4 (Tʲ4) is a 43-aminoacid peptide,
first isolated in human blood platelets;
2 it is
probably an important intracellular modulator
of actin polymerization
3 due to its capacity to
interact with monomeric actin.
1 As an extracel-
lular factor, Tʲ4 has been documented to be
involved in hormonal activities and in modu-
lating the immune response.
1,4 It has also been
found to have anti-inflammatory efficacy
5 and
to be implicated in cardiac protection,
6 angio-
genesis,
7 wound healing,
8 blood coagulation,
2
hair growth and apoptosis.
1,4
Recently, a role for Tʲ4 has been described
in developing foetal salivary glands,
9 in coro-
nary vasculogenesis,
10 and during the develop-
ment  of  different  neural  cell  types  in  rat
brains.
11 In  mouse  embryonic  kidneys,  Tʲ4
activity  has  been  shown  to  increase  during
development, remaining at high levels during
active nephrogenesis.
12 In rat foetal kidneys,
Tʲ4 has  been  identified  in  differentiating
glomeruli,  while  in  adult  rats  it  has  been
mainly found in collecting ducts.
12,13 High lev-
els  of  Tʲ4 mRNA  were  detected  in  normal
human  embryonic  kidneys  and  in  renal
tumors.
14 Recent  studies  have  also  provided
new information concerning a role for Tʲ4 in
human  glomerulosclerosis  and  in  kidney
fibrosis in adults.
15 Tʲ4 also plays an important
role in the development of the reproductive
system. Its secretion has been shown to be
modulated by testosterone and gonadotropin
in mice and pigs.
16-18 Increased levels of Tʲ4 in
the rat ovary have been correlated with the
process of luteinization
16 under the influence
of human chorionic gonadotropin, which stim-
ulates Tʲ4 gene expression.
17 The Tʲ4 gene is
downregulated  at  transcriptional  level  by
androgen activity in prostate cancer cell cul-
ture.
19 Presence of Tʲ4 has been reported dur-
ing the formation of actin-based pseudopodia
in tumoral cells, facilitating cell migration and
prostate  cancer  progression.
20 Our  research
has also shown high Tʲ4 presence in tumour
infiltrating mast cells.
21 Overall, our research
suggests that Tʲ4 has an important role in the
development of different embryonic and adult
organs. Due to controversy in the scientific
community regarding the role of Tʲ4 in health
and disease, this study was aimed at verifying
if similarities exist between Tʲ4 presence dur-
ing development and in adult life, and at dis-
cussing the putative role played by Tʲ4 in both
situations.  We also found it necessary to bet-
ter  investigate  the  presence  of  Tʲ4 in  the
human urinary and reproductive tract of foe-
tuses and adults in order to add new scientific
data for a more complete description of the
several, and not completely known, functions
of this versatile peptide.
Materials and Methods
Four  human  foetuses,  two  males  and  two
females, with gestational age ranging from 14
to 27 weeks, and four adults, two males and
two females 35, 66, 68 and 72 year-old respec-
tively, were selected for this study. In all cases,
no pathological changes were evident in the
organs examined in this study. We obtained
tissue samples at autopsy from each subject
including the following segments of the male
and female genitourinary tract: kidney, blad-
der, uterus, ovary, testicle and prostate. Tissue
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samples were fixed in 10% formalin, routinely
processed  and  paraffin-embedded.  Immuno  -
histochemistry was performed on 5 ʼm-thick
sections, using the labelled streptavidin-biotin
complex  system  (LSAB2,  Dako)  in  a  Dako
Autostainer (DakoCytomation, Carpintera, CA,
USA). Heat-induced antigen retrieval was car-
ried  out  by  steaming  unstained  sections  in
Target Retrieval Solution (Dako TRS pH 6.1)
for 30 min. Tissue sections were incubated (30
min at room temperature) with the monoclon-
al  anti-thymosin  ʲ4  antibody  (Bachem,
Bubendorf, Switzer  land). Sections of a reac-
tive human adult lymph node with activated
macrophages were used as positive controls.
22
As a negative control the same procedure was
applied omitting the primary antibody. 
Ethics statements
The study protocol and written consent forms
were  approved  by  the  Ethics  Human  Studies
Committee  of  University  Medical  Centre  of
Cagliari (according to the instructions of the
Declaration of Helsinki). Full written consent
forms were obtained from the parents of the
newborns and all rules were respected. For the
specimens  from  adults,  we  obtained  written
consent from their next of kin.
Results
The  immunostaining  for  Tʲ4 appeared
homogeneous  or  granular  and  was  always
restricted to the cytoplasm of positive cells. No
nuclear reactivity was observed in this study.
No significant differences were found in the
immunohistochemical pattern for Tʲ4 among
the four foetuses analyzed, as well as the four
adults observed in this study (Table 1). The
immunoreactivity for Tʲ4 in foetal kidneys par-
alleled  the  immunoreactivity  in  the  adult.  A
weak diffuse cytoplasmic positivity was detect-
ed in developmental and mature ducts while
the glomeruli were constantly negative (Figure
1a,b). In the bladder, a weak immunoreactivity
of the peptide was observed in the immature
transitional  epithelium,  which  changed  to  a
coarse  granular  reactivity  in  the  mature
epithelium of the adult bladder (Figure 2a,b).
The surrounding stroma showed mild diffuse
immunoreactivity of Tʲ4in the foetus and focal
in adults (Figure 2b). No immunoreactivity for
Tʲ4 was observed in foetal endometrial glands.
Only  scattered  stromal  cells  showed  a  weak
cytoplasmic immunoreactivity (Figure 3a). A
mild,  granular  cytoplasmic  immunoreactivity
of Tʲ4was present in the endometrial glands of
adults,  while  the  absence  of  any  significant
immunoreactivity  was  found  in  the  stroma
(Figure 3b). No reactivity for Tʲ4 was detected
in the foetal or adult prostatic gland epithelium
(Figure 4a,b). We found a diffuse immunore-
activity of Tʲ4 in the stroma of adult prostate
(Figure 4b), but no reactivity was detected in
the foetal prostate stroma (Figure 4a). A fine
granular positivity was present in the foetal
ovary (Figure 5a), while immunoreactivity of
the peptide was homogeneously weak in adult
oocytes (Figure 5b). Stroma was negative in
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Figure  1.  Kidney.  (a)  Foetuses:  a  diffuse
cytoplasmic  immunoreactivity  of  Tʲ4 is
present in developing ducts (arrow). The
immature glomuruli are negative (arrow-
head). Scale bar: 25 µm. (b) Adults: pri-
mary and secondary ducts show a diffuse
cytoplasmic  immunoreactivity  of  Tʲ
(arrow).  The  glomeruli  are  negative
(arrowhead). Scale bar: 25 µm.
Figure 2. Bladder. (a) Foetuses: the developing
transitional epithelium shows a weak and dif-
fuse  cytoplasmic  immuoreactivity  of  Tʲ4
(arrow). The surrounding stroma shows a mild
diffuse immunoreactivity of the peptide. Scale
bar: 50 µm. (b) Adults: perinuclear coarse gran-
ules, immunoreactive for Tʲ4, are detected in
the  cytoplasm  of  transitional  epithelium
(arrow). The stroma shows a focal positivity of
the peptide (arrowhead). Scale bar: 50 µm.
Figure  3.  Endometrium.  (a)  Foetuses:  no
immunoreactivity of Tʲ4 is observed in devel-
oping endometrial glands (arrow). Only scat-
tered  stromal  cells  show  a  weak  cytoplasmic
immunoreactivity (arrowhead). Scale bar: 100
µm. Inset: scattered stromal cells with a cyto-
plasmic immunoreactivity (arrows). Scale bar:
25 µm. (b) Adults: a mild granular cytoplasmic
immunoreactivity  of Tʲ4  is  observed  in  the
endometrial glands (arrow) while the surround-
ing stroma has no significant immunoreactivity
of the peptide. Scale bar: 25 µm.
Table 1. Immunoreactivity of Tʲ4 in differ-
ent  organs  and  cells  of  the  human  geni-
tourinary tract.
Foetus Aduld
Kidney
Ducts Diffuse Diffuse
Glomeruli Negative Negative
Bladder
Transitional epithelium Focal Diffuse
Stroma Negative Focal
Endometrium
Glands Negative Diffuse
Stromal cells Focal Diffuse
Prostate
Glands Negative Focal
Stroma Negative Diffuse
Isolated cells Focal Diffuse
Ovary
Oocyte Focal Diffuse
Testicle
Spermatic ducts Negative Focal
Interstitial cells Focal Diffuse[European Journal of Histochemistry 2010; 54:e43] [page 203]
both adult and in foetal ovaries (Figure 5a,b).
The interstitial cells of the adult testicle were
strongly positive for Tʲ4 while, in the foetus,
the same cells showed a mild immunoreactivi-
ty for the peptide (Figure 6a,b). Moreover, a
mild reactivity of Tʲ4 was observed in the sper-
matic ducts of the adult testicle (Figure 6b).
Discussion
This is the first comprehensive study that
analyzes Tʲ4 presence in the human genitouri-
nary tract, and compares the presence of this
peptide during development with its reactivity
in the adult. We convincingly demonstrate that
Tʲ4 presence is particular for every organ and,
inside each organ, it appears restricted to cer-
tain structures or to particular cell types.  Many
studies in experimental animals and recently
in humans suggest that Tʲ4 could play a rele-
vant role during development.
9,23 Our data con-
firms this hypothesis. In this study, we find
that  Tʲ4 is  present  during  intrauterine  life
even in the genitourinary tract, and reveal that
immunoreactivity for this peptide may change
during postnatal life with marked differences
between foetal and adult organs. Our previous
studies  on  Tʲ4 protein  presence  in  salivary
glands
9 and in the gastrointestinal tract
23 first
disclosed the uneven distribution of the pep-
tide in different organs of the same system and
within each organ in the different epithelial
and  mesenchymal  structures  and  cells.
Moreover, in recent years, Tʲ4 presence has
been  reported  to  increase  in  different
tumors,
24-26 mainly  in  its  infiltrative  borders
and in their metastastic stage (Nemolato et al,
unpublished data). The uneven distribution of
Tʲ4 among different organs as well as among
different cell types within each organ is con-
firmed by this study also in the genitourinary
tract.  Tʲ4 was  clearly  present  in  all  organs
examined in this study; it was more diffuse in
kidney, adult bladder and in interstitial cells of
the testis. 
Interestingly, we found differences in this
study  between  foetal  and  mature  organs.  In
general, we found direct associations between
presence of Tʲ4 and the degree of development
in all the organs tested. The presence of a rela-
tionship between Tʲ4 presence and the devel-
opmental  status  does  not  coincide  with  our
previous  data  regarding  the  gastrointestinal
tract.
23 In previous studies, Tʲ4 presence pat-
terns were characterized by a higher presence
in the foetus and by a marked decrease in the
adult  suggesting  a  major  role  of  Tʲ4 during
embryogenesis.  This  hypothesis  was  con-
firmed by our studies of Tʲ4 content in human
saliva,
9 which clearly showed high Tʲ4 levels
during  gestation  followed  by  the  disappear-
ance of the peptide in the adult saliva. Our
study reinforces our hypothesis that Tʲ4 func-
tions are not totally known and stresses the
different  function  this  peptide  could  play  in
different human organs, not only during devel-
opment, but also even during adult life. Some
peculiar features related to the patchy Tʲ4 dis-
tribution  in  different  organs  deserve  to  be
noted in: i) kidney restriction of Tʲ4 reactivity
to ducts and tubules with completely spared
glomeruli (Figure 1a,b); ii) a positivity in the
oocytes  of  the  ovary  (Figure  5a,b);  iii)
immunoreactivity restricted to interstitial cells
in the testis (Figure 6a,b). What is the rela-
tionship between these very different types of
cells?  For  the  time  being,  we  have  no  clear
answer.  The  immunoreactivity  of  oocytes  of
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Figure 4. Prostate. (a) Foetuses: no  immu  -
no  reacti  vity  of  Tʲ4  is  observed  in  the
prostate  glands  and  in  the  surrounding
stroma. Scale bar: 50 µm. (b) Adults: no
significant  immuoreactivity  of  Tʲ4  is
detected  in  the  prostate  glands. The  sur-
rounding  stroma  shows  a  diffuse
immunoreactivity for the peptide (arrow-
head).  Scale  bar:  50  µm.  Inset:  at  higher
magnification, no significant immunoreac-
tivity for Tʲ4 is observed in the prostate
gland. Scale bar: 25 µm.
Figure  5.  Ovary.  (a)  Foetuses:  scattered
Tʲ4 reactive fine granules are present in
the  cytoplasm  of  the  oocyte  (arrow).  A
weak diffuse immunoreactivity of the sur-
rounding stroma is detected. Scale bar: 25
µm. (b) Adults: a weak and homogeneous
cytoplasmic immunoreactivity for Tʲ4 is
detected in the oocyte of the primary fol-
licle (arrow). A weak diffuse immunopos-
itivity  in  the  surrounding  stroma  is
observed. Scale bar: 25 µm.
Figure 6. Testicle. (a) Foetuses: no immuno  -
reactivity for Tʲ4 is observed in the imma-
ture spermatic ducts (arrow). A mild cyto-
plasmic immunoreactivity of the peptide is
observed in isolated interstitial cells (arrow-
head). Scale bar: 25 µm. (b) Adults: a granu-
lar cytoplasmic immunoreactivity of Tʲ4 is
detected in the interstitial cells of the testicle
(arrow). A weak immunoreactivity is obser -
ved in the cells of the spermatic ducts (arrow-
head). Scale bar: 50 µm Inset: cells of the
spermatic ducts with a weak immunoreactiv-
ity (arrows). Scale bar: 25 µm.[page 204] [European Journal of Histochemistry 2010; 54:e43]
Tʲ4 in the foetal ovary and its increase in the
adult oocytes indicates a role of the peptide not
only in germ cell development but also in its
maintenance during adult life. 
In this study, Tʲ4 was frequently detected
not only inside of cells but also in the stroma
surrounding gland structures both in foetuses
and in adults. Considering the fact that the
extracellular  forms  of  beta-thymosins  have
been shown to selectively prevent neuronal cell
death,
27 we can speculate that the same role
could  be  played  by  Tʲ4 in  the  genitourinary
tract during development. This role should be
elucidated in further studies. Finally, our study
clearly shows that further work is required to
better understand the presence of Tʲ4 and its
impacts  on  development  and  on  biological
behaviour  of  adult  cells  in  different  human
organs, which confirms Tʲ4 as a versatile pep-
tide with several, mostly unknown important
functions in human health and disease.
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